Condition
Carcinoma Nasal Vestibule
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Research Leaders
17 sponsors active, led by University Hospital, Zürich
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Not Yet Recruiting1
Clinical Trials (1)
Research Network
Active Sponsors
- University Hospital, Zürich1
- UMC Utrecht, Utrecht, the Netherlands1
- University of Navarra1
- Saint John's Cancer Center of Lublin1
- Institut de Cancérologie de Lorraine1